Literature DB >> 16123760

Changes in accumbal and pallidal pCREB and deltaFosB in morphine-sensitized rats: correlations with receptor-evoked electrophysiological measures in the ventral pallidum.

John McDaid1, Jeanine E Dallimore, Alexander R Mackie, T Celeste Napier.   

Abstract

Activation of mu-opioid receptors in the ventral pallidum (VP) is important for the induction of behavioral sensitization to morphine in rats. The present study was designed to ascertain if neurons within the VP demonstrate sensitization at a time when morphine-induced behavioral sensitization occurred (ie 3 or 14 days after five once-daily injections of 10 mg/kg i.p. morphine) in rats. Western blotting was used to evaluate transcription factors altered by opiates, CREB and deltaFosB. CREB levels did not change in the VP, but there was a significant decrease in levels of its active, phosphorylated form (pCREB) at both 3- and 14-days withdrawal. DeltaFosB levels were elevated following a 3-day withdrawal, but returned to normal by 14 days. This profile also was obtained from nucleus accumbens tissue. In a separate group of similarly treated rats, in vivo electrophysiological recordings of VP neuronal responses to microiontophoretically applied ligands were carried out after 14-days withdrawal. The firing rate effects of local applications of morphine were diminished in rats withdrawn from i.p. morphine. Repeated i.p. morphine did not alter GABA-mediated suppression of firing, or the rate enhancing effects of the D1 dopamine receptor agonist SKF82958 or glutamate. However, VP neurons from rats withdrawn from repeated i.p. morphine showed a higher propensity to enter a state of depolarization inactivation to locally applied glutamate. Overall, these findings reveal that decreased pCREB in brain regions such as the VP accompanies persistent behavioral sensitization to morphine and that this biochemical alteration may influence the excitability of neurons in this brain region.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16123760      PMCID: PMC1464405          DOI: 10.1038/sj.npp.1300854

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  66 in total

1.  Discrimination of striatopallidum and extended amygdala in the rat: a role for parvalbumin immunoreactive neurons?

Authors:  Daniel S Zahm; Simona Grosu; Joi C Irving; Evelyn A Williams
Journal:  Brain Res       Date:  2003-07-18       Impact factor: 3.252

2.  Interactions between the mu opioid agonist DAMGO and substance P in regulation of the ventral pallidum.

Authors:  I Mitrovic; T C Napier
Journal:  Synapse       Date:  1996-07       Impact factor: 2.562

3.  Dopamine and glutamate release in the nucleus accumbens and ventral tegmental area of rat following lateral hypothalamic self-stimulation.

Authors:  Z B You; Y Q Chen; R A Wise
Journal:  Neuroscience       Date:  2001       Impact factor: 3.590

4.  Alterations in morphine-induced reward, locomotor activity, and thermoregulation in CREB-deficient mice.

Authors:  Carrie L Walters; Misty Godfrey; Xiao Li; Julie A Blendy
Journal:  Brain Res       Date:  2005-01-25       Impact factor: 3.252

5.  Chronic morphine treatment alters NMDA receptor-mediated synaptic transmission in the nucleus accumbens.

Authors:  G Martin; S H Ahmed; T Blank; J Spiess; G F Koob; G R Siggins
Journal:  J Neurosci       Date:  1999-10-15       Impact factor: 6.167

6.  Tolerance development to the biphasic effects of morphine on locomotor activity and brain acetylcholine in the rat.

Authors:  M R Vasko; E F Domino
Journal:  J Pharmacol Exp Ther       Date:  1978-12       Impact factor: 4.030

7.  Regional reward differences within the ventral pallidum are revealed by microinjections of a mu opiate receptor agonist.

Authors:  P I Johnson; J R Stellar; A D Paul
Journal:  Neuropharmacology       Date:  1993-12       Impact factor: 5.250

8.  Pharmacological studies of the regulation of chronic FOS-related antigen induction by cocaine in the striatum and nucleus accumbens.

Authors:  H E Nye; B T Hope; M B Kelz; M Iadarola; E J Nestler
Journal:  J Pharmacol Exp Ther       Date:  1995-12       Impact factor: 4.030

9.  Induction of chronic Fos-related antigens in rat brain by chronic morphine administration.

Authors:  H E Nye; E J Nestler
Journal:  Mol Pharmacol       Date:  1996-04       Impact factor: 4.436

10.  Repeated and chronic morphine administration causes differential long-lasting changes in dopaminergic neurotransmission in rat striatum without changing its delta- and kappa-opioid receptor regulation.

Authors:  G H Tjon; T J De Vries; E Ronken; F Hogenboom; G Wardeh; A H Mulder; A N Schoffelmeer
Journal:  Eur J Pharmacol       Date:  1994-02-03       Impact factor: 4.432

View more
  18 in total

Review 1.  The ventral pallidum: Subregion-specific functional anatomy and roles in motivated behaviors.

Authors:  David H Root; Roberto I Melendez; Laszlo Zaborszky; T Celeste Napier
Journal:  Prog Neurobiol       Date:  2015-04-06       Impact factor: 11.685

Review 2.  Review. Transcriptional mechanisms of addiction: role of DeltaFosB.

Authors:  Eric J Nestler
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-10-12       Impact factor: 6.237

Review 3.  Natural rewards, neuroplasticity, and non-drug addictions.

Authors:  Christopher M Olsen
Journal:  Neuropharmacology       Date:  2011-04-01       Impact factor: 5.250

4.  The atypical antidepressant mirtazapine attenuates expression of morphine-induced place preference and motor sensitization.

Authors:  Steven M Graves; Amanda L Persons; Jennifer L Riddle; T Celeste Napier
Journal:  Brain Res       Date:  2012-07-20       Impact factor: 3.252

Review 5.  Epigenetic Mechanisms of Opioid Addiction.

Authors:  Caleb J Browne; Arthur Godino; Marine Salery; Eric J Nestler
Journal:  Biol Psychiatry       Date:  2019-07-08       Impact factor: 13.382

6.  Region-dependent attenuation of mu opioid receptor-mediated G-protein activation in mouse CNS as a function of morphine tolerance.

Authors:  L J Sim-Selley; K L Scoggins; M P Cassidy; L A Smith; W L Dewey; F L Smith; D E Selley
Journal:  Br J Pharmacol       Date:  2007-06-18       Impact factor: 8.739

Review 7.  Ventral pallidum roles in reward and motivation.

Authors:  Kyle S Smith; Amy J Tindell; J Wayne Aldridge; Kent C Berridge
Journal:  Behav Brain Res       Date:  2008-10-08       Impact factor: 3.332

8.  Distinct patterns of DeltaFosB induction in brain by drugs of abuse.

Authors:  L I Perrotti; R R Weaver; B Robison; W Renthal; I Maze; S Yazdani; R G Elmore; D J Knapp; D E Selley; B R Martin; L Sim-Selley; R K Bachtell; D W Self; E J Nestler
Journal:  Synapse       Date:  2008-05       Impact factor: 2.562

Review 9.  Glutamatergic substrates of drug addiction and alcoholism.

Authors:  Justin T Gass; M Foster Olive
Journal:  Biochem Pharmacol       Date:  2007-06-30       Impact factor: 5.858

10.  CB1 Cannabinoid Agonist (WIN55,212-2) Within the Basolateral Amygdala Induced Sensitization to Morphine and Increased the Level of μ-Opioid Receptor and c-fos in the Nucleus Accumbens.

Authors:  Marzieh Molaei; Zahra Fatahi; Jalal Zaringhalam; Abbas Haghparast
Journal:  J Mol Neurosci       Date:  2016-01-23       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.